Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $9.23 and traded as high as $9.39. Bavarian Nordic A/S shares last traded at $9.29, with a volume of 4,552 shares changing hands.
Bavarian Nordic A/S Trading Down 3.4 %
The firm has a market cap of $2.12 billion, a P/E ratio of 13.00 and a beta of 1.65. The business’s 50-day moving average is $9.17 and its two-hundred day moving average is $10.06.
Bavarian Nordic A/S Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Further Reading
- Five stocks we like better than Bavarian Nordic A/S
- Retail Stocks Investing, Explained
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Industrial Products Stocks Investing
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What is a SEC Filing?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with MarketBeat.com's FREE daily email newsletter.
